Citation: T. Arora et Df. Jelinek, IFN-ALPHA REGULATES ANTIVIRAL AND GROWTH-RESPONSES VIA DIFFERENT MECHANISMS - ROLE OF THE MAPK SIGNALING PATHWAY IN IFN-STIMULATED MITOGENESIS, European cytokine network, 9(3), 1998, pp. 356-356
Authors:
ISAACSON JA
ARENDT BK
TSCHUMPER RC
JELINEK DF
Citation: Ja. Isaacson et al., IL-6-STIMULATED MYELOMA CELL-PROLIFERATION - EVIDENCE FOR INDUCTION OF AUTOCRINE IGF-L EXPRESSION, The FASEB journal, 12(5), 1998, pp. 6262-6262
Citation: T. Arora et Df. Jelinek, DIFFERENTIAL MYELOMA CELL RESPONSIVENESS TO INTERFERON-ALPHA CORRELATES WITH DIFFERENTIAL INDUCTION OF P19(INK4D) AND CYCLIN D2 EXPRESSION, The Journal of biological chemistry, 273(19), 1998, pp. 11799-11805
Citation: Df. Jelinek et al., A ROLE FOR INSULIN-LIKE-GROWTH-FACTOR IN THE REGULATION OF IL-6-RESPONSIVE HUMAN MYELOMA CELL-LINE GROWTH, The Journal of immunology, 159(1), 1997, pp. 487-496
Authors:
JELINEK DF
AAGAARDTILLERY KM
ARENDT BK
ARORA T
TSCHUMPER RC
WESTENDORF JJ
Citation: Df. Jelinek et al., DIFFERENTIAL HUMAN MULTIPLE-MYELOMA CELL-LINE RESPONSIVENESS TO INTERFERON-ALPHA - ANALYSIS OF TRANSCRIPTION FACTOR ACTIVATION AND INTERLEUKIN-6 RECEPTOR EXPRESSION, The Journal of clinical investigation, 99(3), 1997, pp. 447-456
Citation: Rc. Tschumper et Df. Jelinek, ANALYSIS OF INTERLEUKIN-6 (IL-6)-STIMULATED DIFFERENTIAL GENE-EXPRESSION IN HUMAN MYELOMA CELLS, The FASEB journal, 10(6), 1996, pp. 2648-2648
Citation: T. Arora et Df. Jelinek, ANALYSIS OF THE DIFFERENTIAL-EFFECTS OF INTERFERON-ALPHA (IFN-ALPHA) ON MYELOMA CELL-PROLIFERATION, The FASEB journal, 10(6), 1996, pp. 2649-2649
Authors:
WESTENDORF JJ
AHMANN GJ
GREIPP PR
WITZIG TE
KYLE RA
LUST JA
JELINEK DF
Citation: Jj. Westendorf et al., ESTABLISHMENT AND CHARACTERIZATION OF 3 MYELOMA CELL-LINES THAT DEMONSTRATE VARIABLE CYTOKINE RESPONSES AND ABILITIES TO PRODUCE AUTOCRINE INTERLEUKIN-6, Leukemia, 10(5), 1996, pp. 866-876
Citation: Km. Aagaardtillery et Df. Jelinek, A ROLE FOR PHOSPHATIDYLINOSITOL 3-KINASE IN GENERATING T-CELL HELP FOR B-CELL GROWTH AND DIFFERENTIATION, The Journal of immunology, 157(7), 1996, pp. 2769-2778
Citation: Jj. Westendorf et Df. Jelinek, GROWTH-REGULATORY PATHWAYS IN MYELOMA - EVIDENCE FOR AUTOCRINE ONCOSTATIN-M EXPRESSION, The Journal of immunology, 157(7), 1996, pp. 3081-3088
Citation: Km. Aagaardtillery et Df. Jelinek, PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION IN NORMAL HUMAN B-LYMPHOCYTES - DIFFERENTIAL SENSITIVITY OF GROWTH AND DIFFERENTIATION TO WORTMANNIN, The Journal of immunology, 156(12), 1996, pp. 4543-4554
Citation: Km. Aagaardtillery et Df. Jelinek, DIFFERENTIAL ACTIVATION OF A CALCIUM-DEPENDENT ENDONUCLEASE IN HUMAN B-LYMPHOCYTES - ROLE IN IONOMYCIN-INDUCED APOPTOSIS, The Journal of immunology, 155(7), 1995, pp. 3297-3307
Citation: Df. Jelinek et Jk. Braaten, ROLE OF IL-12 IN HUMAN B-LYMPHOCYTE PROLIFERATION AND DIFFERENTIATION, The Journal of immunology, 154(4), 1995, pp. 1606-1613
Authors:
BILLADEAU D
JELINEK DF
SHAH N
LEBIEN TW
VANNESS B
Citation: D. Billadeau et al., INTRODUCTION OF AN ACTIVATED N-RAS ONCOGENE ALTERS THE GROWTH-CHARACTERISTICS OF THE INTERLEUKIN 6-DEPENDENT MYELOMA CELL-LINE ANBL6, Cancer research, 55(16), 1995, pp. 3640-3646
Citation: Jj. Westendorf et Df. Jelinek, ONCOSTATIN-M IS AN AUTOCRINE GROWTH MYELOMA CELLS - EVIDENCE SUPPORTING ABERRANT SIGNALING IN MYELOMA, Blood, 86(10), 1995, pp. 1091-1091
Citation: Jj. Westendorf et al., EXPRESSION AND FUNCTION OF FAS (APO-1 CD95) IN PATIENT MYELOMA CELLS AND MYELOMA CELL-LINES/, Blood, 85(12), 1995, pp. 3566-3576
Citation: Km. Aagaardtillery et Df. Jelinek, THE EFFECTS OF THE IMMUNOSUPPRESSANT RAPAMYCIN ON EVENTS ASSOCIATED WITH HUMAN B-LYMPHOCYTE ACTIVATION, The FASEB journal, 8(5), 1994, pp. 10000789-10000789
Citation: Jj. Westendorf et al., DIFFERENTIAL-EFFECTS OF CD40 STIMULATION IN NORMAL AND MALIGNANT HUMAN PLASMA-CELLS, The FASEB journal, 8(5), 1994, pp. 10001012-10001012
Citation: Jk. Braaten et Df. Jelinek, ENHANCEMENT OF HUMAN B-CELL DIFFERENTIATION BY INTERLEUKIN-12, The FASEB journal, 8(4), 1994, pp. 10000256-10000256
Authors:
WESTENDORF JJ
AHMANN GJ
ARMITAGE RJ
SPRIGGS MK
LUST JA
GREIPP PR
KATZMANN JA
JELINEK DF
Citation: Jj. Westendorf et al., CD40 EXPRESSION IN MALIGNANT PLASMA-CELLS - ROLE IN STIMULATION OF AUTOCRINE IL-6 SECRETION BY A HUMAN MYELOMA CELL-LINE, The Journal of immunology, 152(1), 1994, pp. 117-128
Citation: Km. Aagaardtillery et Df. Jelinek, INHIBITION OF HUMAN B-LYMPHOCYTE CELL-CYCLE PROGRESSION AND DIFFERENTIATION BY RAPAMYCIN, Cellular immunology, 156(2), 1994, pp. 493-507
Citation: Df. Jelinek et Km. Aagaardtillery, EFFECTS OF INTERFERON-ALPHA ON MYELOMA CELL-PROLIFERATION - MECHANISMS OF INTERLEUKIN-6 ANTAGONISM, Blood, 84(10), 1994, pp. 10000176-10000176
Citation: Jj. Westendorf et al., EXPRESSION AND FUNCTION OF FAS (APO-1 CD95) IN MYELOMA CELLS - EVIDENCE FOR A PROTECTIVE FACTOR THAT INHIBITS FAS-INDUCED APOPTOSIS OF PLASMA-CELLS, Blood, 84(10), 1994, pp. 10000177-10000177
Citation: D. Billadeau et al., INTRODUCTION OF AN ACTIVATED N-RAS ONCOGENE ALTERS THE GROWTH-CHARACTERISTICS OF THE IL-6 DEPENDENT MYELOMA CELL-LINE ANBL6, Blood, 84(10), 1994, pp. 10000294-10000294
Authors:
MATHEW P
GREIPP PR
JELINEK DF
JENKINS RB
RITLAND S
PAYA CV
Citation: P. Mathew et al., THE P65 (REL-A) TRANSACTIVATING SUBUNIT OF NF KAPPA-B AND THE T(11 14) IN MULTIPLE-MYELOMA/, Blood, 84(10), 1994, pp. 10000656-10000656